STAT Plus: Gilead to pay $97 million for allegedly using a charity to pay kickbacks to Medicare patients
Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it paid to a charity were actually kickbacks to Medicare patients used to cover out-of-pockets costs for its medicine used to treat a type of high blood pressure.
This is only the latest instance in which federal authorities have cracked down on such arrangements between drug makers and patient assistance charities.
